Return to site

Biosimulation Market Insights, Trends | Global Industry Report

Know the detailed information regarding the major factors influencing the growth of the biosimulation market.

Factors such as increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of the market.

The biosimulation market is highly competitive with the presence of various players. Some of the major players operating in the market are Certara (US), Simulation Plus (US), Dassault Systèmes (France), Schrödinger (US), ACD/Labs (Canada), Chemical Computing Group (Canada), Physiomics (UK), Evidera (US), In silico biosciences (US), INOSIM Software (Germany), Insilico Biotechnology (Germany), LeadInvent Technologies (India), Rosa (US), Nuventra Pharma (US), and Genedata (Switzerland).
The biosimulation market is expected to reach USD 2.88 Billion by 2022 from USD 1.20 Billion in 2016 growing at a CAGR of 15.9%
Product launches & upgradations accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. Some of the companies that adopted this strategy include Certara, Simulation Plus, Schrödinger, ACD/Labs, and Chemical Computing Group.
Certara is one of the leading players in the biosimulation market. This leading position of the company can be attributed to its strong brand recognition and extensive product portfolio in the market. The company has a vast presence in North America, Europe, Asia, and Australia. In order to maintain its leading position in the biosimulation market the company focuses on inorganic and organic growth strategies like product launches and upgradations, expansions, acquisitions, and partnerships. For instance, in September 2016, the company acquired d3 Medicine (Australia) to enhance the company’s expertise in the field of modeling and simulation modeling, simulation, and regulatory science powerhouse. Likewise, in October 2017, the company launched Phoenix 8.0 PK/PD Modeling and Simulation software.
Read Press Release On Biosimulation Market Insights:

The report provides insights on the following:

1 Product Development: Product portfolios of the top players in the biosimulation market.
2 Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the biosimulation market.
3 Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various biosimulation products and services across geographies.
All Posts

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly